10796732

Source:http://linkedlifedata.com/resource/pubmed/id/10796732

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:10796732	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:10796732	lifeskim:mentions	umls-concept:C0003232	lld:lifeskim
pubmed-article:10796732	lifeskim:mentions	umls-concept:C0010674	lld:lifeskim
pubmed-article:10796732	pubmed:issue	2	lld:pubmed
pubmed-article:10796732	pubmed:dateCreated	2000-7-6	lld:pubmed
pubmed-article:10796732	pubmed:abstractText	Lung damage associated with persistent infection by Pseudomonas aeruginosa is the major cause of morbidity and mortality in people with cystic fibrosis. Nebulised antibiotics are commonly used for treatment of this infection.	lld:pubmed
pubmed-article:10796732	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10796732	pubmed:language	eng	lld:pubmed
pubmed-article:10796732	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10796732	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:10796732	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10796732	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10796732	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:10796732	pubmed:issn	1469-493X	lld:pubmed
pubmed-article:10796732	pubmed:author	pubmed-author:SinghMM	lld:pubmed
pubmed-article:10796732	pubmed:author	pubmed-author:MukhopadhyayS...	lld:pubmed
pubmed-article:10796732	pubmed:author	pubmed-author:RyanGG	lld:pubmed
pubmed-article:10796732	pubmed:issnType	Electronic	lld:pubmed
pubmed-article:10796732	pubmed:owner	NLM	lld:pubmed
pubmed-article:10796732	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:10796732	pubmed:pagination	CD001021	lld:pubmed
pubmed-article:10796732	pubmed:dateRevised	2004-11-17	lld:pubmed
pubmed-article:10796732	pubmed:meshHeading	pubmed-meshheading:10796732...	lld:pubmed
pubmed-article:10796732	pubmed:meshHeading	pubmed-meshheading:10796732...	lld:pubmed
pubmed-article:10796732	pubmed:meshHeading	pubmed-meshheading:10796732...	lld:pubmed
pubmed-article:10796732	pubmed:meshHeading	pubmed-meshheading:10796732...	lld:pubmed
pubmed-article:10796732	pubmed:meshHeading	pubmed-meshheading:10796732...	lld:pubmed
pubmed-article:10796732	pubmed:meshHeading	pubmed-meshheading:10796732...	lld:pubmed
pubmed-article:10796732	pubmed:meshHeading	pubmed-meshheading:10796732...	lld:pubmed
pubmed-article:10796732	pubmed:meshHeading	pubmed-meshheading:10796732...	lld:pubmed
pubmed-article:10796732	pubmed:meshHeading	pubmed-meshheading:10796732...	lld:pubmed
pubmed-article:10796732	pubmed:year	2000	lld:pubmed
pubmed-article:10796732	pubmed:articleTitle	Nebulised anti-pseudomonal antibiotics for cystic fibrosis.	lld:pubmed
pubmed-article:10796732	pubmed:affiliation	Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia, 6008. gryan@cyllene.uwa.edu.au	lld:pubmed
pubmed-article:10796732	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:10796732	pubmed:publicationType	Review	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:10796732	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:10796732	lld:pubmed